EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Enzyme‐mediated remodeling of the extracellular matrix and glycocalyx to enhance immunotherapy in solid tumors

Navid Mirmohammadsadegh iD, Mohsen Amin iD

Bioengineering & Translational Medicine · 2026-11 · 11 (6)

DOI: 10.1002/btm2.70180 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Bioengineering & Translational Medicine, online erschienen am 28.09.2026. Verfasst von Navid Mirmohammadsadegh und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug and Food Control, Faculty of Pharmacy Tehran University of Medical Sciences Tehran Iran. Die Arbeit nennt 164 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The tumor‐associated extracellular matrix (ECM) and glycocalyx form a dynamic barrier that provides physical shielding and immunosuppressive signaling, leading to therapeutic resistance. A growing body of evidence supports enzyme‐based strategies to remodel these barriers and improve therapeutic access to tumors. This review examines enzymes that act as “path cleansers” by cleaving components of the ECM or the glycocalyx to restore the efficacy of immunotherapies. Moreover, some enzymes may exert effects beyond barrier remodeling, including modulation of signaling pathways, enhancement of immune responses, or even direct effects on the tumor. In this review, barrier‐remodeling enzymes, categorized into different classes, are discussed as potential adjuncts to cancer immunotherapy. This review also highlights the bioengineering approaches and the delivery strategies used to enhance tumor specificity, efficacy, and safety. While such therapeutic strategies show promising outcomes, the evidence hierarchy and potential translational risks are also discussed. Improved patient stratification and computationally guided enzyme discovery and protein engineering, including strategies to reduce immunogenicity, can facilitate the clinical translation of enzyme‐assisted immunotherapy.

Schlagwörter

Stichwörter der Autor:innen

ECM‐targeting enzymesextracellular matrix (ECM)glycocalyximmunotherapymicrobial‐derived enzymessolid tumorstumor microenvironment (TME)

Autor:innen und Institutionen

  • Department of Drug and Food Control, Faculty of Pharmacy Tehran University of Medical Sciences Tehran Iran.
  • Nutraceutics Research Center Tehran University of Medical Sciences Tehran Iran.

ORCID-Profile: Navid Mirmohammadsadegh, Mohsen Amin

Zitieren

APA

Mirmohammadsadegh, N., & Amin, M. (2026). Enzyme‐mediated remodeling of the extracellular matrix and glycocalyx to enhance immunotherapy in solid tumors. Bioengineering & Translational Medicine, 11(6). https://doi.org/10.1002/btm2.70180

Vancouver

Mirmohammadsadegh N, Amin M. Enzyme‐mediated remodeling of the extracellular matrix and glycocalyx to enhance immunotherapy in solid tumors. Bioengineering & Translational Medicine. 2026;11(6). doi:10.1002/btm2.70180

BibTeX
@article{Mirmohammadsadegh2026,
  author = {Mirmohammadsadegh, Navid and Amin, Mohsen},
  title = {Enzyme‐mediated remodeling of the extracellular matrix and glycocalyx to enhance immunotherapy in solid tumors},
  journal = {Bioengineering & Translational Medicine},
  year = {2026},
  volume = {11},
  number = {6},
  doi = {10.1002/btm2.70180}
}
Kostenlos starten →